Copyright Reports & Markets. All rights reserved.

Global Urticaria Drug Market Research Report 2021

Request for Sample of this report
Buy now

1 Urticaria Drug Market Overview

  • 1.1 Product Overview and Scope of Urticaria Drug
  • 1.2 Urticaria Drug Segment by Type
    • 1.2.1 Global Urticaria Drug Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Acute Urticaria
    • 1.2.3 Chronic Urticaria
  • 1.3 Urticaria Drug Segment by Application
    • 1.3.1 Urticaria Drug Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
    • 1.3.5 Others
  • 1.4 Global Urticaria Drug Market Size Estimates and Forecasts
    • 1.4.1 Global Urticaria Drug Revenue 2016-2027
    • 1.4.2 Global Urticaria Drug Sales 2016-2027
    • 1.4.3 Urticaria Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Urticaria Drug Market Competition by Manufacturers

  • 2.1 Global Urticaria Drug Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Urticaria Drug Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Urticaria Drug Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Urticaria Drug Manufacturing Sites, Area Served, Product Type
  • 2.5 Urticaria Drug Market Competitive Situation and Trends
    • 2.5.1 Urticaria Drug Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Urticaria Drug Players Market Share by Revenue
    • 2.5.3 Global Urticaria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Urticaria Drug Retrospective Market Scenario by Region

  • 3.1 Global Urticaria Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Urticaria Drug Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Urticaria Drug Market Facts & Figures by Country
    • 3.3.1 North America Urticaria Drug Sales by Country
    • 3.3.2 North America Urticaria Drug Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Urticaria Drug Market Facts & Figures by Country
    • 3.4.1 Europe Urticaria Drug Sales by Country
    • 3.4.2 Europe Urticaria Drug Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Urticaria Drug Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Urticaria Drug Sales by Region
    • 3.5.2 Asia Pacific Urticaria Drug Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Urticaria Drug Market Facts & Figures by Country
    • 3.6.1 Latin America Urticaria Drug Sales by Country
    • 3.6.2 Latin America Urticaria Drug Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Urticaria Drug Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Urticaria Drug Sales by Country
    • 3.7.2 Middle East and Africa Urticaria Drug Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Urticaria Drug Historic Market Analysis by Type

  • 4.1 Global Urticaria Drug Sales Market Share by Type (2016-2021)
  • 4.2 Global Urticaria Drug Revenue Market Share by Type (2016-2021)
  • 4.3 Global Urticaria Drug Price by Type (2016-2021)

5 Global Urticaria Drug Historic Market Analysis by Application

  • 5.1 Global Urticaria Drug Sales Market Share by Application (2016-2021)
  • 5.2 Global Urticaria Drug Revenue Market Share by Application (2016-2021)
  • 5.3 Global Urticaria Drug Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Johnson and Johnson Services
    • 6.1.1 Johnson and Johnson Services Corporation Information
    • 6.1.2 Johnson and Johnson Services Description and Business Overview
    • 6.1.3 Johnson and Johnson Services Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Johnson and Johnson Services Product Portfolio
    • 6.1.5 Johnson and Johnson Services Recent Developments/Updates
  • 6.2 Amneal Pharmaceuticals
    • 6.2.1 Amneal Pharmaceuticals Corporation Information
    • 6.2.2 Amneal Pharmaceuticals Description and Business Overview
    • 6.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Amneal Pharmaceuticals Product Portfolio
    • 6.2.5 Amneal Pharmaceuticals Recent Developments/Updates
  • 6.3 Pfizer
    • 6.3.1 Pfizer Corporation Information
    • 6.3.2 Pfizer Description and Business Overview
    • 6.3.3 Pfizer Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Pfizer Product Portfolio
    • 6.3.5 Pfizer Recent Developments/Updates
  • 6.4 Taro Pharmaceutical Industries Novartis AG
    • 6.4.1 Taro Pharmaceutical Industries Novartis AG Corporation Information
    • 6.4.2 Taro Pharmaceutical Industries Novartis AG Description and Business Overview
    • 6.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Taro Pharmaceutical Industries Novartis AG Product Portfolio
    • 6.4.5 Taro Pharmaceutical Industries Novartis AG Recent Developments/Updates
  • 6.5 Akorn
    • 6.5.1 Akorn Corporation Information
    • 6.5.2 Akorn Description and Business Overview
    • 6.5.3 Akorn Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Akorn Product Portfolio
    • 6.5.5 Akorn Recent Developments/Updates
  • 6.6 Teva Pharmaceutical Industries
    • 6.6.1 Teva Pharmaceutical Industries Corporation Information
    • 6.6.2 Teva Pharmaceutical Industries Description and Business Overview
    • 6.6.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Teva Pharmaceutical Industries Product Portfolio
    • 6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
  • 6.7 Genentech
    • 6.6.1 Genentech Corporation Information
    • 6.6.2 Genentech Description and Business Overview
    • 6.6.3 Genentech Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Genentech Product Portfolio
    • 6.7.5 Genentech Recent Developments/Updates
  • 6.8 Xolair
    • 6.8.1 Xolair Corporation Information
    • 6.8.2 Xolair Description and Business Overview
    • 6.8.3 Xolair Urticaria Drug Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Xolair Product Portfolio
    • 6.8.5 Xolair Recent Developments/Updates

7 Urticaria Drug Manufacturing Cost Analysis

  • 7.1 Urticaria Drug Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Urticaria Drug
  • 7.4 Urticaria Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Urticaria Drug Distributors List
  • 8.3 Urticaria Drug Customers

9 Urticaria Drug Market Dynamics

  • 9.1 Urticaria Drug Industry Trends
  • 9.2 Urticaria Drug Growth Drivers
  • 9.3 Urticaria Drug Market Challenges
  • 9.4 Urticaria Drug Market Restraints

10 Global Market Forecast

  • 10.1 Urticaria Drug Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Urticaria Drug by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Urticaria Drug by Type (2022-2027)
  • 10.2 Urticaria Drug Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Urticaria Drug by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Urticaria Drug by Application (2022-2027)
  • 10.3 Urticaria Drug Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Urticaria Drug by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Urticaria Drug by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Acute Urticaria
    Chronic Urticaria

    Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Johnson and Johnson Services
    Amneal Pharmaceuticals
    Pfizer
    Taro Pharmaceutical Industries Novartis AG
    Akorn
    Teva Pharmaceutical Industries
    Genentech
    Xolair

    Buy now